AgPlus Diagnostics is delighted to announce the appointment of Fiona Marshall as CEO starting in January 2018. Fiona has worked for BBI Group since 2006 where she is currently the Managing Director of BBI Detection and was formerly the MD of BBI Solutions.
Christopher Getley, Chairman, said ‘Fiona’s strong record of both operational and commercial success will be a great asset to the team at AgPlus as it secures its first long term commitments with its B2B partners.’
About AgPlus Diagnostics Ltd:
AgPlus has developed a diagnostic platform that delivers the market requirement of a rapid, ultra sensitive, fully quantitative PoC test for use across a wide range of clinical applications. Through collaboration with B2B partners, AgPlus provides clients with a customised diagnostic assay system able to reach the greatest number of patients worldwide in the shortest possible time. The AgPlus platform is used to match each patient’s critical condition with the right drug at the right time, significantly reducing both cost and anxiety.
You can adjust all of your cookie settings by navigating the tabs on the left hand side.